Advanced Pharmacotherapeutics in Respiratory and Renal Diseases
PostgraduateTAS-CSA7232025
Enrolments for this course are closed, but you may have other options to start studying now. Book a consultation to learn more.
- Study method
- 100% online
- Assessments
- 100% online
- Entry requirements
- Part of a degree
- Duration
- 14 weeks
- Start dates
- 24 Feb 2025
- Loan available
- HECS-HELP and FEE-HELP available
Advanced Pharmacotherapeutics in Respiratory and Renal Diseases
About this subject
Upon successful completion of this subject, the student should be able to:
- Create a search strategy to collate evidence-based respiratory and/or renal related research.
- Evaluate respiratory and renal medication therapy using an evidence-based approach.
- Apply evidence-based and contemporary clinical skills in the management of respiratory or renal disease.
- Interpret and transmit knowledge, skills and ideas to specialist and non-specialist audiences.
- Refer to MyLO for study topics
TAS-CSA723 is a self-directed, fully online subject, that explores a variety of disease states and their management, using a series of patient cases linked to assignment-based questions, to enable you to enhance your knowledge in the area of clinical pharmacy and pharmaceutical care. This subject covers the medication management and clinical pharmacy issues in respiratory and renal diseases.
- Short Case with Specific Questions (25%)
- Answering Clinical Questions to a Detailed Clinical Case (40%)
- Practice-based Summary (15%)
- Scientific Presentation on Clinical Topic (20%)
For textbook details check your university's handbook, website or learning management system (LMS).
Wherever you are, the University of Tasmania brings its island campus to you through a growing range of online programs across art and design, business, education, health, science, sustainability, technology, and more. It’s never too late to switch things up. Kickstart that career you’ve been dreaming about, or upskill for the one you’re in. You’ll also become a part of the world's leading university on climate action.
Learn more about UTAS.
Explore UTAS courses.
- QS World University Ranking 2025, within Australia:
- 20
- Times Higher Education World University Ranking 2025, within Australia:
- 19
Entry requirements
Part of a degree
To enrol in this subject you must be accepted into one of the following degrees:
Elective
- TAS-CPH-GDI-2025 - Graduate Diploma of Clinical Pharmacy
- TAS-CPH-GCE-2025 - Graduate Certificate in Clinical Pharmacy
Prior study
You must either have successfully completed the following subject(s) before starting this subject, or enrol in the following subject(s) to study at the same time or prior to this subject:
one of
TAS-CSA721-Introduction to Advanced Clinical Pharmacy Practice (no longer available)
- TAS-CSA731-Evidence Based Pharmacotherapeutic Practice
Additional requirements
No additional requirements
Study load
- 0.125 EFTSL
- This is in the range of 10 to 12 hours of study each week.
Equivalent full time study load (EFTSL) is one way to calculate your study load. One (1.0) EFTSL is equivalent to a full-time study load for one year.
Find out more information on Commonwealth Loans to understand what this means to your eligibility for financial support.
Related degrees
Once you’ve completed this subject it can be credited towards one of the following courses
Graduate Diploma of Clinical Pharmacy
PostgraduateTAS-CPH-GDI
Graduate Certificate in Clinical Pharmacy
PostgraduateTAS-CPH-GCE